In April 2015, Kamwenge District, western Uganda reported a measles outbreak. We investigated the outbreak to identify potential exposures that facilitated measles transmission, assess vaccine effectiveness (VE) and vaccination coverage (VC), and recommend prevention and control measures.
For this investigation, a probable case was defined as onset of fever and generalized maculopapular rash, plus ≥1 of the following symptoms: Coryza, conjunctivitis, or cough. A confirmed case was defined as a probable case plus identification of measles-specific IgM in serum. For case-finding, we reviewed patients’ medical records and conducted in-home patient examination. In a case-control study, we compared exposures of case-patients and controls matched by age and village of residence. For children aged 9 m-5y, we estimated VC using the percent of children among the controls who had been vaccinated against measles, and calculated VE using the formula, VE = 1 - ORM-H, where ORM-H was the Mantel-Haenszel odds ratio associated with having a measles vaccination history.
We identified 213 probable cases with onset between April and August, 2015. Of 23 blood specimens collected, 78% were positive for measles-specific IgM. Measles attack rate was highest in the youngest age-group, 0-5y (13/10,000), and decreased as age increased. The epidemic curve indicated sustained propagation in the community. Of the 50 case-patients and 200 controls, 42% of case-patients and 12% of controls visited health centers during their likely exposure period (ORM-H = 6.1; 95% CI = 2.7–14). Among children aged 9 m-5y, VE was estimated at 70% (95% CI: 24–88%), and VC at 75% (95% CI: 67–83%). Excessive crowding was observed at all health centers; no patient triage-system existed.
The spread of measles during this outbreak was facilitated by patient mixing at crowded health centers, suboptimal VE and inadequate VC. We recommended emergency immunization campaign targeting children <5y in the affected sub-counties, as well as triaging and isolation of febrile or rash patients visiting health centers.
Onoja A, Adeniji A, Faneye A. Measles complications in a Nigerian hospital setting. Clin Rev Opin. 2013;5(2):18–23. CrossRef
Simons E, Ferrari M, Fricks J, Wannemuehler K, Anand A, Burton A, et al. Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. Lancet (London, England). 2012;379(9832):2173–8. CrossRef
Global Measles and Rubella Strategic plan. http://apps.who.int/iris/bitstream/10665/44855/1/9789241503396_eng.pdf. Accessed 07 Jan 2015.
African Regional Guidelines for Measles and Rubella Surveillance. www.afro.who.int/sites/default/files/2017-06/who-african-regional-measles-and-rubella-surveillance-guidelines_updated-draft-version-april-2015_1.pdf. Accessed 11 Jan 2016.
Guidelines for epidemic preparedness and response to measles outbreaks. www.who.int/csr/resources/publications/measles/whocdscsrisr991.pdf. Accessed 05 Dec 2015.
Hope K, Boyd R, Conaty S, Maywood P. Measles transmission in health care waiting rooms: implications for public health response. Western Pac Surveill Response J. 2012;3(4):33–38.
Akramuzzaman S, Cutts F, Hossain M, Wahedi O, Nahar N, Islam D, et al. Measles vaccine effectiveness and risk factors for measles in Dhaka. Bangladesh Bull World Health Organ. 2002;80(10):776. PubMed
Hayden GF. Clinical review: measles vaccine failure a survey of causes and means of prevention. Clin Pediatr. 1979;18(3):155–6. CrossRef
Akande T. A review of measles vaccine failure in developing countries. Niger Med Pract. 2007;52(5–6):112–6.
Module on best practices for measles surveillance. http://apps.who.int/iris/bitstream/10665/67192/1/WHO_V-B_01.43_eng.pdf. Accessed 26 Aug 2016.
De Serres G, Boulianne N, Defay F, Brousseau N, Benoît M, Lacoursière S, Guillemette F, Soto J, Ouakki M, Ward BJ, et al. Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12–14 months versus 15 months of age. Clin Infect Dis. 2012;55(3):394–402. CrossRefPubMed
Control CD. Prevention: increased transmission and outbreaks of measles-European region, 2011. MMWR Morb Mortal Wkly Rep. 2011;60(47):1605.
Sugerman D, Barskey A, Delea M, Ortega-Sanchez I, Bi, D, Ralston K, et al. Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated. Pediatrics. 2010;125(4):747–755.
- Factors contributing to measles transmission during an outbreak in Kamwenge District, Western Uganda, April to August 2015
Joseph K. B. Matovu
Alex Ario Riolexus
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
e.Med Kampagnen-Visual, Mail Icon II